take result
report result afternoon remain posit bias
share driven view favor set-up neurodegen
space ow aducanumab progress toward approv alzheim
updat phase data ftd-grn
expect provid find csf biomark brain imag potenti sign
efficaci cognitive/behavior test importantli phase remain
schedul start year base case assum phase ftd-grn trial
wont demonstr impact cognition/behavior there longer follow-up
 howev suspect updat keep investor engag
separ alzheim program continu advanc though remain
outsid main narr think updat year could begin shed
light program valu like accret close year
point ew highlight program recent day
upcom catalyst beyond balanc year expect see
number alzheim updat phase data phase start data
updat plan ad/pd ind-en studi first-in-human
next month ftd program continu enrol
phase phase data also expect year
adjust estim base result trend adjust model
reflect modest opex adjust net impact chang bring
ep estim
quarterli annual ep usd
consensu number bloomberg receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
return equiti ttm
idc link barclay live interact chart
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
overweight construct share
ahead like posit biomark readout
outsid share offer favor risk-reward
proof concept/biomark data year
posit could begin accret valu
posit neurocognit data phase ftd
studi line-of-sight toward acceler
approv file would upsid
right drive po higher latter rapidli
transform compani commercial-stag
failur demonstr biomark improv
ftd provid potenti read-through broader
immuno-neurolog platform/approach
chang model
base result trend adjust model reflect modest opex
adjust net impact chang bring ep estim
carter gould herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
author contribut research report research analyst unless otherwis indic public date top report
reflect local time report produc may differ releas date provid gmt
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas refer
procedur pleas
unless otherwis indic price sourc bloomberg reflect close price relev trade market may
last avail price time public
barclay bank plc and/or affili lead manag co-lead manag publicli disclos offer secur issuer
 employe non-execut director barclay plc director issuer
cd barclay bank plc and/or affili market-mak debt secur issu issuer
ce barclay bank plc and/or affili market-mak equiti secur issu issuer
barclay bank plc and/or affili receiv compens invest bank servic issuer past month
 barclay bank plc and/or affili expect receiv intend seek compens invest bank servic issuer
within next month
fa barclay bank plc and/or affili benefici own class equiti secur issuer calcul accord
us regul
fb barclay bank plc and/or affili benefici own long posit class equiti secur issuer
calcul accord eu regul
fc barclay bank plc and/or affili benefici own short posit class equiti secur issuer
calcul accord eu regul
fd barclay bank plc and/or affili benefici own class equiti secur issuer calcul accord
south korean regul
gd one research analyst fundament credit coverag team member household long posit
common equiti secur issuer
ge one research analyst fundament equiti coverag team member household long posit
common equiti secur issuer
 issuer benefici own class common equiti secur barclay plc
barclay bank plc and/or affili parti agreement issuer provis financi servic barclay bank plc and/or
affili
 barclay bank plc and/or affili liquid provid and/or trade regularli secur issuer and/or relat
 barclay bank plc and/or affili receiv non-invest bank relat compens includ compens brokerag
servic applic issuer within past month
 issuer past month invest bank client barclay bank plc and/or affili
issuer past month non-invest bank client secur relat servic barclay bank plc
and/or affili
 issuer past month non-invest bank client non-secur relat servic barclay bank plc
and/or affili
use
 partner director offic barclay capit canada inc preced month provid servic subject compani
remuner normal cours invest advisori trade execut servic
 barclay bank plc and/or affili corpor broker issuer
 barclay capit canada inc and/or affili receiv compens invest bank servic issuer past
issuer corpor broker barclay plc
barclay bank plc and/or affili provid equiti advisori servic issuer
 equiti secur canadian issuer includ subordin vote restrict share
 equiti secur canadian issuer includ non-vot restrict share
master limit partnership pass-through entiti structur publicli list partnership tax purpos distribut
unit holder may treat return princip investor consult tax advisor invest unit
guid barclay fundament equiti research rate system
coverag analyst use rel rate system rate stock overweight equal weight underweight see definit
rel compani cover analyst team analyst deem industri industri coverag
addit stock rate provid industri view rate outlook industri coverag univers posit neutral
neg see definit rate system use term buy hold sell equival rate system investor
care read entir research report includ definit rate infer content rate alon
overweight stock expect outperform unweight expect total return industri coverag univers
equal weight stock expect perform line unweight expect total return industri coverag univers
underweight stock expect under-perform unweight expect total return industri coverag univers
rate suspend rate target price suspend temporarili due market event made coverag impractic
compli applic regul and/or firm polici certain circumst includ invest bank barclay bank plc
act advisori capac merger strateg transact involv compani
posit industri coverag univers fundamentals/valu improv
neutral industri coverag univers fundamentals/valu steadi neither improv deterior
neg industri coverag univers fundamentals/valu deterior
list compani constitut industri coverag univers
